FOSUN PHARMA (600196.SH) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Dec7

Fosun Pharma's Multiple Products Included in 2025 National Health Insurance Catalog

07:43

Rare Disease Drugs Included in the 2025 Medical Insurance and Commercial Health Insurance Innovative Drug Catalogue

04:09

Dec3

Fosun Pharma Receives NMPA Approval to Initiate Clinical Trials for Anti-Cancer Drug FXS887

08:32

Dec2

Shanghai Fosun Pharma's subsidiary drug registration application accepted

12:45

Fosun Pharmaceutical's Subsidiary Receives Acceptance for Heparin Sodium Injection Drug Registration Application

09:50

Nov28

Fosun Pharma Announces Pricing Basis and Policy for Medical Services

13:58

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 9.879 B, Net Income 821.33 M, EPS 0.3099

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 10.09 B, Net Income 937.21 M, EPS 0.3495

Aug4

Distribution Plan(CST)

Cash dividend 0.32 CNY

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More